Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain

The vast majority of clinically approved protein kinase inhibitors target the ATP-binding pocket directly. Consequently, many inhibitors have broad selectivity profiles and most have significant off-target effects. Allosteric inhibitors are generally more selective, but are difficult to identify bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, Selena G., Oleksy, Arkadiusz, Cavazza, Tommaso, Richards, Mark W., Vernos, Isabelle, Matthews, David, Bayliss, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967828/
https://www.ncbi.nlm.nih.gov/pubmed/27411893
http://dx.doi.org/10.1098/rsob.160089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967828/
https://www.ncbi.nlm.nih.gov/pubmed/27411893
http://dx.doi.org/10.1098/rsob.160089

Ejemplares similares